Verified source report
Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs
New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.
Share
Send this story
Share the canonical link, post it to a feed, or send it directly.
What happened
According to KFF Health News’s source item, Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs, New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.
Context
The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-05-18T09:00:00+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs via KFF Health News. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
This source-cited VINI report links to the original publisher record. VINI does not republish third-party article bodies without rights clearance. 1 source listed.
Source links
- Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity DrugsKFF Health News - 2026-05-18T09:00:00+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.